ImpediMed Limited

OTCPK:IPDQ.F Stock Report

Market Cap: US$65.4m

ImpediMed Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:IPDQ.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 24BuyUS$10,312Christine Emmanuel-DonnellyIndividual295,000US$0.035
20 Nov 24BuyUS$31,996Fiona BonesIndividual920,000US$0.035
05 Sep 24BuyUS$19,172Andrew GrantIndividual600,000US$0.032
30 Aug 24BuyUS$6,769Christine Emmanuel-DonnellyIndividual200,000US$0.034
30 Aug 24BuyUS$33,575Andrew GrantIndividual1,000,000US$0.034
14 May 24BuyUS$5,297Christine Emmanuel-DonnellyIndividual100,000US$0.053
08 May 24BuyUS$32,932Janelle DelaneyIndividual634,177US$0.052
06 May 24BuyUS$5,329Andrew GrantIndividual100,000US$0.054
25 Mar 24BuyUS$65,394Janelle DelaneyIndividual1,149,576US$0.058
08 Mar 24BuyUS$1,773,586Paradice Investment Management Pty Ltd.Company26,860,865US$0.066
08 Mar 24SellUS$1,653,325Australian Ethical Investment LimitedCompany25,000,000US$0.066
04 Mar 24BuyUS$64,919Janelle DelaneyIndividual1,137,634US$0.061
29 Feb 24BuyUS$7,294Andrew GrantIndividual230,000US$0.057
28 Feb 24BuyUS$6,602Christine Emmanuel-DonnellyIndividual121,952US$0.054
31 Jan 24SellUS$39,829Paradice Investment Management Pty Ltd.Company548,611US$0.073

Insider Trading Volume

Insider Buying: IPDQ.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IPDQ.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders89,120,0524.4%
Private Companies147,896,1987.31%
Institutions284,209,65214%
General Public1,502,330,91174.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 25.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.13%
Paradice Investment Management Pty Ltd.
144,301,807US$4.7m-17.2%0.23%
6.05%
Australian Ethical Investment Limited
122,513,808US$4.0m6.25%0.67%
1.59%
Sunlora Pty Ltd
32,125,000US$1.0m69.1%no data
1.16%
Hamish Jones
23,538,705US$760.8k10.7%no data
1.11%
MBA Investments Pty Ltd
22,490,990US$727.0k0%no data
1%
Gregory Brown
20,300,000US$656.1k-3.79%no data
1%
Henderson International Pty. Ltd.
20,236,167US$654.1k0%no data
0.79%
Pakasoluto Pty Limited
16,011,422US$517.5k0%no data
0.77%
Hsien Soo
15,662,797US$506.3k1.74%no data
0.76%
First Samuel Limited
15,281,508US$493.9k0%0.43%
0.67%
Bsd Pty Ltd
13,495,000US$436.2k1.47%no data
0.62%
Jonnola Pty Ltd
12,482,704US$403.5k0%no data
0.61%
Hme Soo Holdings Pty Ltd
12,320,921US$398.2k0%no data
0.47%
Stephen Mahnken
9,500,000US$307.1k18.8%no data
0.47%
Dior Mahnken
9,500,000US$307.1k18.8%no data
0.39%
Acadia Park Pty Ltd
7,945,858US$256.8k0%no data
0.2%
Janelle Delaney
4,082,590US$132.0k3.88%no data
0.16%
Wales Corporation Pty Ltd
3,179,998US$102.8k0%no data
0.14%
Standard Company Pty Ltd
2,927,492US$94.6k0%no data
0.11%
Sa Funds Pty Limited
2,302,096US$74.4k0%no data
0.11%
Matra Capital Pty Ltd
2,230,770US$72.1k0%no data
0.11%
Andrew Grant
2,152,468US$69.6k7.62%no data
0.1%
Dimensional Fund Advisors LP
2,092,529US$67.6k0.19%no data
0.1%
McGregor Grant
2,055,000US$66.4k0%no data
0.057%
Christine Emmanuel-Donnelly
1,154,351US$37.3k95.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 17:36
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ImpediMed Limited is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Russell WrightBarclay Pearce Capital Pty Limited
Matthijs SmithCanaccord Genuity